AGP Picks
View all

Sci-Tech Montana
Provided by AGP

Sci-Tech Montana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Montana.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 11, 2026

Codexis Reports Second Quarter 2026 Financial Results
Aug. 11, 2026

Codexis Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 11, 2026

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
Aug. 11, 2026

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

Indeterminate GlobeNewswire
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
Aug. 11, 2026

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
Aug. 11, 2026

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Indeterminate GlobeNewswire
Inuvo Reports Second Quarter 2026 Results
Aug. 11, 2026

Inuvo Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
Aug. 11, 2026

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Erasca Reports Second Quarter 2026 Business Updates and Financial Results
Aug. 11, 2026

Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
Aug. 11, 2026

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire
Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1
Aug. 11, 2026

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug. 11, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Leonardo DRS Demonstrates Defeat of Group 1-2 Unmanned Aerial System Threats for Fielded SGT STOUT M-SHORAD
Aug. 11, 2026

Leonardo DRS Demonstrates Defeat of Group 1-2 Unmanned Aerial System Threats for Fielded SGT STOUT M-SHORAD

Indeterminate GlobeNewswire
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug. 11, 2026

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Aug. 11, 2026

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Indeterminate GlobeNewswire
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 11, 2026

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Wrap Reports Q2 Revenue of $2.1 Million, Up 103% Year Over Year; ATF Classifies BolaWrap 150 as Non-Firearm, Non-Weapon
Aug. 11, 2026

Wrap Reports Q2 Revenue of $2.1 Million, Up 103% Year Over Year; ATF Classifies BolaWrap 150 as Non-Firearm, Non-Weapon

Indeterminate GlobeNewswire
Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results
Aug. 11, 2026

Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results

Indeterminate GlobeNewswire
NovelMed Advances NM5072 for Multiple Ocular Disorders
Aug. 11, 2026

NovelMed Advances NM5072 for Multiple Ocular Disorders

Indeterminate GlobeNewswire
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del segundo trimestre de 2026
Aug. 11, 2026

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del segundo trimestre de 2026

Indeterminate GlobeNewswire
SuperLuxuryReps.is Expands Super Clone Watches Collection With Greater Focus on QC and Precision
Aug. 11, 2026

SuperLuxuryReps.is Expands Super Clone Watches Collection With Greater Focus on QC and Precision

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech Montana

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.